![](/img/cover-not-exists.png)
Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
Frith, Peter A, Thompson, Philip J, Ratnavadivel, Rajeev, Chang, Catherina L, Bremner, Peter, Day, Peter, Frenzel, Christina, Kurstjens, NicolVolume:
70
Language:
english
Journal:
Thorax
DOI:
10.1136/thoraxjnl-2014-206670
Date:
June, 2015
File:
PDF, 1.12 MB
english, 2015